nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Weight increased—Doxorubicin—pancreatic cancer	0.000276	0.000293	CcSEcCtD
Topiramate—Epistaxis—Epirubicin—pancreatic cancer	0.000276	0.000293	CcSEcCtD
Topiramate—Pruritus—Gemcitabine—pancreatic cancer	0.000275	0.000293	CcSEcCtD
Topiramate—Infection—Docetaxel—pancreatic cancer	0.000274	0.000292	CcSEcCtD
Topiramate—Weight decreased—Doxorubicin—pancreatic cancer	0.000274	0.000292	CcSEcCtD
Topiramate—Sinusitis—Epirubicin—pancreatic cancer	0.000274	0.000291	CcSEcCtD
Topiramate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000274	0.000291	CcSEcCtD
Topiramate—Diarrhoea—Irinotecan—pancreatic cancer	0.000273	0.000291	CcSEcCtD
Topiramate—Agranulocytosis—Epirubicin—pancreatic cancer	0.000273	0.00029	CcSEcCtD
Topiramate—Pneumonia—Doxorubicin—pancreatic cancer	0.000272	0.000289	CcSEcCtD
Topiramate—Shock—Docetaxel—pancreatic cancer	0.000272	0.000289	CcSEcCtD
Topiramate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000271	0.000288	CcSEcCtD
Topiramate—Pruritus—Fluorouracil—pancreatic cancer	0.000271	0.000288	CcSEcCtD
Topiramate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00027	0.000288	CcSEcCtD
Topiramate—Infestation NOS—Doxorubicin—pancreatic cancer	0.00027	0.000287	CcSEcCtD
Topiramate—Infestation—Doxorubicin—pancreatic cancer	0.00027	0.000287	CcSEcCtD
Topiramate—Tachycardia—Docetaxel—pancreatic cancer	0.00027	0.000287	CcSEcCtD
Topiramate—Skin disorder—Docetaxel—pancreatic cancer	0.000268	0.000285	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000268	0.000285	CcSEcCtD
Topiramate—Bradycardia—Epirubicin—pancreatic cancer	0.000267	0.000284	CcSEcCtD
Topiramate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000266	0.000283	CcSEcCtD
Topiramate—Renal failure—Doxorubicin—pancreatic cancer	0.000266	0.000283	CcSEcCtD
Topiramate—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000265	0.000282	CcSEcCtD
Topiramate—Dizziness—Irinotecan—pancreatic cancer	0.000264	0.000281	CcSEcCtD
Topiramate—Haemoglobin—Epirubicin—pancreatic cancer	0.000264	0.00028	CcSEcCtD
Topiramate—Stomatitis—Doxorubicin—pancreatic cancer	0.000264	0.00028	CcSEcCtD
Topiramate—Anorexia—Docetaxel—pancreatic cancer	0.000263	0.00028	CcSEcCtD
Topiramate—Rhinitis—Epirubicin—pancreatic cancer	0.000263	0.00028	CcSEcCtD
Topiramate—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000263	0.000279	CcSEcCtD
Topiramate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000263	0.000279	CcSEcCtD
Topiramate—Haemorrhage—Epirubicin—pancreatic cancer	0.000262	0.000279	CcSEcCtD
Topiramate—Hepatitis—Epirubicin—pancreatic cancer	0.000262	0.000279	CcSEcCtD
Topiramate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000262	0.000278	CcSEcCtD
Topiramate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000261	0.000277	CcSEcCtD
Topiramate—Pharyngitis—Epirubicin—pancreatic cancer	0.00026	0.000277	CcSEcCtD
Topiramate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000259	0.000275	CcSEcCtD
Topiramate—Oedema peripheral—Epirubicin—pancreatic cancer	0.000258	0.000275	CcSEcCtD
Topiramate—Hypotension—Docetaxel—pancreatic cancer	0.000258	0.000274	CcSEcCtD
Topiramate—Haematuria—Doxorubicin—pancreatic cancer	0.000258	0.000274	CcSEcCtD
Topiramate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000258	0.000274	CcSEcCtD
Topiramate—Urethral disorder—Epirubicin—pancreatic cancer	0.000257	0.000273	CcSEcCtD
Topiramate—Epistaxis—Doxorubicin—pancreatic cancer	0.000255	0.000271	CcSEcCtD
Topiramate—Vomiting—Irinotecan—pancreatic cancer	0.000254	0.00027	CcSEcCtD
Topiramate—Sinusitis—Doxorubicin—pancreatic cancer	0.000254	0.00027	CcSEcCtD
Topiramate—Dizziness—Fluorouracil—pancreatic cancer	0.000253	0.000269	CcSEcCtD
Topiramate—Visual impairment—Epirubicin—pancreatic cancer	0.000253	0.000269	CcSEcCtD
Topiramate—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000252	0.000268	CcSEcCtD
Topiramate—Rash—Irinotecan—pancreatic cancer	0.000252	0.000268	CcSEcCtD
Topiramate—Dermatitis—Irinotecan—pancreatic cancer	0.000252	0.000268	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000252	0.000268	CcSEcCtD
Topiramate—Headache—Irinotecan—pancreatic cancer	0.00025	0.000266	CcSEcCtD
Topiramate—Insomnia—Docetaxel—pancreatic cancer	0.00025	0.000266	CcSEcCtD
Topiramate—Paraesthesia—Docetaxel—pancreatic cancer	0.000248	0.000264	CcSEcCtD
Topiramate—Erythema multiforme—Epirubicin—pancreatic cancer	0.000248	0.000264	CcSEcCtD
Topiramate—Vomiting—Gemcitabine—pancreatic cancer	0.000248	0.000263	CcSEcCtD
Topiramate—Bradycardia—Doxorubicin—pancreatic cancer	0.000247	0.000263	CcSEcCtD
Topiramate—Dyspnoea—Docetaxel—pancreatic cancer	0.000246	0.000262	CcSEcCtD
Topiramate—Somnolence—Docetaxel—pancreatic cancer	0.000246	0.000261	CcSEcCtD
Topiramate—Rash—Gemcitabine—pancreatic cancer	0.000245	0.000261	CcSEcCtD
Topiramate—Dermatitis—Gemcitabine—pancreatic cancer	0.000245	0.000261	CcSEcCtD
Topiramate—Eye disorder—Epirubicin—pancreatic cancer	0.000245	0.000261	CcSEcCtD
Topiramate—Tinnitus—Epirubicin—pancreatic cancer	0.000245	0.00026	CcSEcCtD
Topiramate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000244	0.000259	CcSEcCtD
Topiramate—Headache—Gemcitabine—pancreatic cancer	0.000244	0.000259	CcSEcCtD
Topiramate—Flushing—Epirubicin—pancreatic cancer	0.000243	0.000259	CcSEcCtD
Topiramate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000243	0.000259	CcSEcCtD
Topiramate—Vomiting—Fluorouracil—pancreatic cancer	0.000243	0.000259	CcSEcCtD
Topiramate—Rhinitis—Doxorubicin—pancreatic cancer	0.000243	0.000259	CcSEcCtD
Topiramate—Dyspepsia—Docetaxel—pancreatic cancer	0.000243	0.000259	CcSEcCtD
Topiramate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000243	0.000258	CcSEcCtD
Topiramate—Hepatitis—Doxorubicin—pancreatic cancer	0.000243	0.000258	CcSEcCtD
Topiramate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000241	0.000257	CcSEcCtD
Topiramate—Rash—Fluorouracil—pancreatic cancer	0.000241	0.000257	CcSEcCtD
Topiramate—Dermatitis—Fluorouracil—pancreatic cancer	0.000241	0.000256	CcSEcCtD
Topiramate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000241	0.000256	CcSEcCtD
Topiramate—Decreased appetite—Docetaxel—pancreatic cancer	0.00024	0.000255	CcSEcCtD
Topiramate—Headache—Fluorouracil—pancreatic cancer	0.00024	0.000255	CcSEcCtD
Topiramate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00024	0.000255	CcSEcCtD
Topiramate—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000239	0.000254	CcSEcCtD
Topiramate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000239	0.000254	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000238	0.000254	CcSEcCtD
Topiramate—Fatigue—Docetaxel—pancreatic cancer	0.000238	0.000253	CcSEcCtD
Topiramate—Angiopathy—Epirubicin—pancreatic cancer	0.000238	0.000253	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000238	0.000253	CcSEcCtD
Topiramate—Nausea—Irinotecan—pancreatic cancer	0.000237	0.000252	CcSEcCtD
Topiramate—Immune system disorder—Epirubicin—pancreatic cancer	0.000237	0.000252	CcSEcCtD
Topiramate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000236	0.000251	CcSEcCtD
Topiramate—Constipation—Docetaxel—pancreatic cancer	0.000236	0.000251	CcSEcCtD
Topiramate—Pain—Docetaxel—pancreatic cancer	0.000236	0.000251	CcSEcCtD
Topiramate—Chills—Epirubicin—pancreatic cancer	0.000235	0.00025	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—pancreatic cancer	0.000234	0.000249	CcSEcCtD
Topiramate—Alopecia—Epirubicin—pancreatic cancer	0.000232	0.000246	CcSEcCtD
Topiramate—Nausea—Gemcitabine—pancreatic cancer	0.000231	0.000246	CcSEcCtD
Topiramate—Mental disorder—Epirubicin—pancreatic cancer	0.00023	0.000244	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000229	0.000244	CcSEcCtD
Topiramate—Malnutrition—Epirubicin—pancreatic cancer	0.000228	0.000243	CcSEcCtD
Topiramate—Erythema—Epirubicin—pancreatic cancer	0.000228	0.000243	CcSEcCtD
Topiramate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000228	0.000242	CcSEcCtD
Topiramate—Nausea—Fluorouracil—pancreatic cancer	0.000227	0.000242	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—pancreatic cancer	0.000227	0.000241	CcSEcCtD
Topiramate—Tinnitus—Doxorubicin—pancreatic cancer	0.000226	0.000241	CcSEcCtD
Topiramate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000226	0.00024	CcSEcCtD
Topiramate—Flushing—Doxorubicin—pancreatic cancer	0.000225	0.000239	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000225	0.000239	CcSEcCtD
Topiramate—Flatulence—Epirubicin—pancreatic cancer	0.000225	0.000239	CcSEcCtD
Topiramate—Tension—Epirubicin—pancreatic cancer	0.000224	0.000238	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—pancreatic cancer	0.000224	0.000238	CcSEcCtD
Topiramate—Nervousness—Epirubicin—pancreatic cancer	0.000222	0.000236	CcSEcCtD
Topiramate—Back pain—Epirubicin—pancreatic cancer	0.000221	0.000235	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—pancreatic cancer	0.00022	0.000234	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—pancreatic cancer	0.00022	0.000233	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000219	0.000233	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000219	0.000233	CcSEcCtD
Topiramate—Body temperature increased—Docetaxel—pancreatic cancer	0.000218	0.000232	CcSEcCtD
Topiramate—Abdominal pain—Docetaxel—pancreatic cancer	0.000218	0.000232	CcSEcCtD
Topiramate—Chills—Doxorubicin—pancreatic cancer	0.000218	0.000232	CcSEcCtD
Topiramate—Vision blurred—Epirubicin—pancreatic cancer	0.000215	0.000229	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—pancreatic cancer	0.000214	0.000228	CcSEcCtD
Topiramate—Mental disorder—Doxorubicin—pancreatic cancer	0.000213	0.000226	CcSEcCtD
Topiramate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000212	0.000225	CcSEcCtD
Topiramate—Erythema—Doxorubicin—pancreatic cancer	0.000211	0.000225	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—pancreatic cancer	0.000211	0.000225	CcSEcCtD
Topiramate—Anaemia—Epirubicin—pancreatic cancer	0.000211	0.000224	CcSEcCtD
Topiramate—Agitation—Epirubicin—pancreatic cancer	0.00021	0.000223	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—pancreatic cancer	0.000208	0.000221	CcSEcCtD
Topiramate—Tension—Doxorubicin—pancreatic cancer	0.000207	0.00022	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000207	0.00022	CcSEcCtD
Topiramate—Malaise—Epirubicin—pancreatic cancer	0.000206	0.000219	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—pancreatic cancer	0.000205	0.000218	CcSEcCtD
Topiramate—Vertigo—Epirubicin—pancreatic cancer	0.000205	0.000218	CcSEcCtD
Topiramate—Syncope—Epirubicin—pancreatic cancer	0.000205	0.000218	CcSEcCtD
Topiramate—Leukopenia—Epirubicin—pancreatic cancer	0.000204	0.000217	CcSEcCtD
Topiramate—Back pain—Doxorubicin—pancreatic cancer	0.000204	0.000217	CcSEcCtD
Topiramate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000204	0.000216	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000203	0.000216	CcSEcCtD
Topiramate—Palpitations—Epirubicin—pancreatic cancer	0.000202	0.000215	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000201	0.000213	CcSEcCtD
Topiramate—Cough—Epirubicin—pancreatic cancer	0.000199	0.000212	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—pancreatic cancer	0.000199	0.000212	CcSEcCtD
Topiramate—Asthenia—Docetaxel—pancreatic cancer	0.000198	0.000211	CcSEcCtD
Topiramate—Convulsion—Epirubicin—pancreatic cancer	0.000198	0.00021	CcSEcCtD
Topiramate—Hypertension—Epirubicin—pancreatic cancer	0.000197	0.00021	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000196	0.000208	CcSEcCtD
Topiramate—Pruritus—Docetaxel—pancreatic cancer	0.000195	0.000208	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—pancreatic cancer	0.000195	0.000208	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—pancreatic cancer	0.000194	0.000207	CcSEcCtD
Topiramate—Chest pain—Epirubicin—pancreatic cancer	0.000194	0.000207	CcSEcCtD
Topiramate—Myalgia—Epirubicin—pancreatic cancer	0.000194	0.000207	CcSEcCtD
Topiramate—Agitation—Doxorubicin—pancreatic cancer	0.000194	0.000206	CcSEcCtD
Topiramate—Anxiety—Epirubicin—pancreatic cancer	0.000194	0.000206	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000193	0.000205	CcSEcCtD
Topiramate—Discomfort—Epirubicin—pancreatic cancer	0.000192	0.000204	CcSEcCtD
Topiramate—Malaise—Doxorubicin—pancreatic cancer	0.000191	0.000203	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—pancreatic cancer	0.00019	0.000202	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—pancreatic cancer	0.00019	0.000202	CcSEcCtD
Topiramate—Syncope—Doxorubicin—pancreatic cancer	0.000189	0.000201	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—pancreatic cancer	0.000189	0.000201	CcSEcCtD
Topiramate—Diarrhoea—Docetaxel—pancreatic cancer	0.000189	0.000201	CcSEcCtD
Topiramate—Confusional state—Epirubicin—pancreatic cancer	0.000188	0.0002	CcSEcCtD
Topiramate—Palpitations—Doxorubicin—pancreatic cancer	0.000187	0.000198	CcSEcCtD
Topiramate—Oedema—Epirubicin—pancreatic cancer	0.000186	0.000198	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000186	0.000197	CcSEcCtD
Topiramate—Infection—Epirubicin—pancreatic cancer	0.000185	0.000197	CcSEcCtD
Topiramate—Cough—Doxorubicin—pancreatic cancer	0.000184	0.000196	CcSEcCtD
Topiramate—Shock—Epirubicin—pancreatic cancer	0.000183	0.000195	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—pancreatic cancer	0.000183	0.000195	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000183	0.000194	CcSEcCtD
Topiramate—Dizziness—Docetaxel—pancreatic cancer	0.000183	0.000194	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000182	0.000194	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—pancreatic cancer	0.000182	0.000194	CcSEcCtD
Topiramate—Tachycardia—Epirubicin—pancreatic cancer	0.000182	0.000193	CcSEcCtD
Topiramate—Skin disorder—Epirubicin—pancreatic cancer	0.000181	0.000192	CcSEcCtD
Topiramate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00018	0.000192	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—pancreatic cancer	0.00018	0.000191	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—pancreatic cancer	0.00018	0.000191	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—pancreatic cancer	0.00018	0.000191	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—pancreatic cancer	0.000179	0.000191	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000179	0.00019	CcSEcCtD
Topiramate—Discomfort—Doxorubicin—pancreatic cancer	0.000178	0.000189	CcSEcCtD
Topiramate—Anorexia—Epirubicin—pancreatic cancer	0.000178	0.000189	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—pancreatic cancer	0.000176	0.000187	CcSEcCtD
Topiramate—Vomiting—Docetaxel—pancreatic cancer	0.000176	0.000187	CcSEcCtD
Topiramate—Rash—Docetaxel—pancreatic cancer	0.000174	0.000185	CcSEcCtD
Topiramate—Hypotension—Epirubicin—pancreatic cancer	0.000174	0.000185	CcSEcCtD
Topiramate—Dermatitis—Docetaxel—pancreatic cancer	0.000174	0.000185	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—pancreatic cancer	0.000174	0.000185	CcSEcCtD
Topiramate—Headache—Docetaxel—pancreatic cancer	0.000173	0.000184	CcSEcCtD
Topiramate—Oedema—Doxorubicin—pancreatic cancer	0.000172	0.000183	CcSEcCtD
Topiramate—Infection—Doxorubicin—pancreatic cancer	0.000171	0.000182	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00017	0.00018	CcSEcCtD
Topiramate—Shock—Doxorubicin—pancreatic cancer	0.00017	0.00018	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000169	0.00018	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000169	0.000179	CcSEcCtD
Topiramate—Insomnia—Epirubicin—pancreatic cancer	0.000169	0.000179	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—pancreatic cancer	0.000168	0.000179	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—pancreatic cancer	0.000167	0.000178	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—pancreatic cancer	0.000167	0.000178	CcSEcCtD
Topiramate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000167	0.000177	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—pancreatic cancer	0.000166	0.000177	CcSEcCtD
Topiramate—Somnolence—Epirubicin—pancreatic cancer	0.000166	0.000176	CcSEcCtD
Topiramate—Anorexia—Doxorubicin—pancreatic cancer	0.000164	0.000175	CcSEcCtD
Topiramate—Nausea—Docetaxel—pancreatic cancer	0.000164	0.000174	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—pancreatic cancer	0.000164	0.000174	CcSEcCtD
Topiramate—Decreased appetite—Epirubicin—pancreatic cancer	0.000162	0.000172	CcSEcCtD
Topiramate—Hypotension—Doxorubicin—pancreatic cancer	0.000161	0.000171	CcSEcCtD
Topiramate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000161	0.000171	CcSEcCtD
Topiramate—Fatigue—Epirubicin—pancreatic cancer	0.000161	0.000171	CcSEcCtD
Topiramate—Pain—Epirubicin—pancreatic cancer	0.000159	0.000169	CcSEcCtD
Topiramate—Constipation—Epirubicin—pancreatic cancer	0.000159	0.000169	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000157	0.000167	CcSEcCtD
Topiramate—Insomnia—Doxorubicin—pancreatic cancer	0.000156	0.000166	CcSEcCtD
Topiramate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000155	0.000165	CcSEcCtD
Topiramate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000154	0.000163	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000154	0.000163	CcSEcCtD
Topiramate—Somnolence—Doxorubicin—pancreatic cancer	0.000153	0.000163	CcSEcCtD
Topiramate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000152	0.000162	CcSEcCtD
Topiramate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000152	0.000161	CcSEcCtD
Topiramate—Decreased appetite—Doxorubicin—pancreatic cancer	0.00015	0.000159	CcSEcCtD
Topiramate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000149	0.000158	CcSEcCtD
Topiramate—Fatigue—Doxorubicin—pancreatic cancer	0.000149	0.000158	CcSEcCtD
Topiramate—Urticaria—Epirubicin—pancreatic cancer	0.000148	0.000157	CcSEcCtD
Topiramate—Pain—Doxorubicin—pancreatic cancer	0.000147	0.000157	CcSEcCtD
Topiramate—Constipation—Doxorubicin—pancreatic cancer	0.000147	0.000157	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—pancreatic cancer	0.000147	0.000157	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—pancreatic cancer	0.000147	0.000157	CcSEcCtD
Topiramate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000142	0.000151	CcSEcCtD
Topiramate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000141	0.00015	CcSEcCtD
Topiramate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000137	0.000146	CcSEcCtD
Topiramate—Urticaria—Doxorubicin—pancreatic cancer	0.000137	0.000146	CcSEcCtD
Topiramate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000136	0.000145	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000136	0.000145	CcSEcCtD
Topiramate—Asthenia—Epirubicin—pancreatic cancer	0.000134	0.000142	CcSEcCtD
Topiramate—Pruritus—Epirubicin—pancreatic cancer	0.000132	0.00014	CcSEcCtD
Topiramate—Diarrhoea—Epirubicin—pancreatic cancer	0.000127	0.000136	CcSEcCtD
Topiramate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000127	0.000135	CcSEcCtD
Topiramate—Asthenia—Doxorubicin—pancreatic cancer	0.000124	0.000132	CcSEcCtD
Topiramate—Dizziness—Epirubicin—pancreatic cancer	0.000123	0.000131	CcSEcCtD
Topiramate—Pruritus—Doxorubicin—pancreatic cancer	0.000122	0.00013	CcSEcCtD
Topiramate—Vomiting—Epirubicin—pancreatic cancer	0.000118	0.000126	CcSEcCtD
Topiramate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000118	0.000125	CcSEcCtD
Topiramate—Rash—Epirubicin—pancreatic cancer	0.000117	0.000125	CcSEcCtD
Topiramate—Dermatitis—Epirubicin—pancreatic cancer	0.000117	0.000125	CcSEcCtD
Topiramate—Headache—Epirubicin—pancreatic cancer	0.000117	0.000124	CcSEcCtD
Topiramate—Dizziness—Doxorubicin—pancreatic cancer	0.000114	0.000121	CcSEcCtD
Topiramate—Nausea—Epirubicin—pancreatic cancer	0.000111	0.000118	CcSEcCtD
Topiramate—Vomiting—Doxorubicin—pancreatic cancer	0.00011	0.000117	CcSEcCtD
Topiramate—Rash—Doxorubicin—pancreatic cancer	0.000109	0.000116	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—pancreatic cancer	0.000109	0.000115	CcSEcCtD
Topiramate—Headache—Doxorubicin—pancreatic cancer	0.000108	0.000115	CcSEcCtD
Topiramate—Nausea—Doxorubicin—pancreatic cancer	0.000102	0.000109	CcSEcCtD
Topiramate—CA5A—Metabolism—GCG—pancreatic cancer	7.82e-05	0.00132	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.81e-05	0.00131	CbGpPWpGaD
Topiramate—CA9—Metabolism—TYMP—pancreatic cancer	7.8e-05	0.00131	CbGpPWpGaD
Topiramate—CA4—Metabolism—GLP1R—pancreatic cancer	7.78e-05	0.00131	CbGpPWpGaD
Topiramate—CA4—Metabolism—DPYD—pancreatic cancer	7.65e-05	0.00129	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CD44—pancreatic cancer	7.61e-05	0.00128	CbGpPWpGaD
Topiramate—CA7—Metabolism—CD44—pancreatic cancer	7.61e-05	0.00128	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	7.51e-05	0.00126	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SMAD4—pancreatic cancer	7.46e-05	0.00126	CbGpPWpGaD
Topiramate—CA2—Metabolism—GLP1R—pancreatic cancer	7.46e-05	0.00126	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PPARG—pancreatic cancer	7.38e-05	0.00124	CbGpPWpGaD
Topiramate—CA6—Metabolism—STK11—pancreatic cancer	7.35e-05	0.00124	CbGpPWpGaD
Topiramate—CA5A—Metabolism—STK11—pancreatic cancer	7.35e-05	0.00124	CbGpPWpGaD
Topiramate—CA2—Metabolism—DPYD—pancreatic cancer	7.34e-05	0.00123	CbGpPWpGaD
Topiramate—CA7—Metabolism—GCG—pancreatic cancer	7.3e-05	0.00123	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GCG—pancreatic cancer	7.3e-05	0.00123	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HES1—pancreatic cancer	7.28e-05	0.00123	CbGpPWpGaD
Topiramate—CA4—Metabolism—SLC2A2—pancreatic cancer	7.26e-05	0.00122	CbGpPWpGaD
Topiramate—CA1—Metabolism—GLP1R—pancreatic cancer	7.15e-05	0.0012	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MMP9—pancreatic cancer	7.14e-05	0.0012	CbGpPWpGaD
Topiramate—CA12—Metabolism—CD44—pancreatic cancer	7.05e-05	0.00119	CbGpPWpGaD
Topiramate—CA1—Metabolism—DPYD—pancreatic cancer	7.03e-05	0.00118	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	6.99e-05	0.00118	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC2A2—pancreatic cancer	6.96e-05	0.00117	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	6.93e-05	0.00117	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.87e-05	0.00116	CbGpPWpGaD
Topiramate—CA7—Metabolism—STK11—pancreatic cancer	6.86e-05	0.00115	CbGpPWpGaD
Topiramate—CA5B—Metabolism—STK11—pancreatic cancer	6.86e-05	0.00115	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—HRAS—pancreatic cancer	6.84e-05	0.00115	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.82e-05	0.00115	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP2—pancreatic cancer	6.78e-05	0.00114	CbGpPWpGaD
Topiramate—CA12—Metabolism—GCG—pancreatic cancer	6.76e-05	0.00114	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP2—pancreatic cancer	6.68e-05	0.00112	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC2A2—pancreatic cancer	6.67e-05	0.00112	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—SRC—pancreatic cancer	6.58e-05	0.00111	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	6.56e-05	0.0011	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—VEGFA—pancreatic cancer	6.42e-05	0.00108	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—pancreatic cancer	6.41e-05	0.00108	CbGpPWpGaD
Topiramate—CA12—Metabolism—STK11—pancreatic cancer	6.36e-05	0.00107	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—STAT3—pancreatic cancer	6.36e-05	0.00107	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—NRAS—pancreatic cancer	6.33e-05	0.00107	CbGpPWpGaD
Topiramate—CA6—Metabolism—TYMS—pancreatic cancer	6.32e-05	0.00106	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TYMS—pancreatic cancer	6.32e-05	0.00106	CbGpPWpGaD
Topiramate—CA9—Metabolism—GLP1R—pancreatic cancer	6.29e-05	0.00106	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	6.28e-05	0.00106	CbGpPWpGaD
Topiramate—CA9—Metabolism—DPYD—pancreatic cancer	6.18e-05	0.00104	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	6.05e-05	0.00102	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—pancreatic cancer	6.04e-05	0.00102	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TYMS—pancreatic cancer	5.9e-05	0.000994	CbGpPWpGaD
Topiramate—CA7—Metabolism—TYMS—pancreatic cancer	5.9e-05	0.000994	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC2A2—pancreatic cancer	5.87e-05	0.000988	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KDR—pancreatic cancer	5.84e-05	0.000982	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—pancreatic cancer	5.77e-05	0.000971	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—HRAS—pancreatic cancer	5.76e-05	0.000969	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MET—pancreatic cancer	5.71e-05	0.000961	CbGpPWpGaD
Topiramate—CA4—Metabolism—CD44—pancreatic cancer	5.62e-05	0.000947	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NOTCH1—pancreatic cancer	5.5e-05	0.000925	CbGpPWpGaD
Topiramate—CA12—Metabolism—TYMS—pancreatic cancer	5.47e-05	0.00092	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—KRAS—pancreatic cancer	5.45e-05	0.000917	CbGpPWpGaD
Topiramate—CA4—Metabolism—GCG—pancreatic cancer	5.39e-05	0.000908	CbGpPWpGaD
Topiramate—CA2—Metabolism—CD44—pancreatic cancer	5.39e-05	0.000908	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	5.33e-05	0.000897	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—HRAS—pancreatic cancer	5.27e-05	0.000886	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	5.26e-05	0.000885	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	5.25e-05	0.000884	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CTNNB1—pancreatic cancer	5.19e-05	0.000874	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PPARG—pancreatic cancer	5.19e-05	0.000873	CbGpPWpGaD
Topiramate—CA1—Metabolism—CD44—pancreatic cancer	5.17e-05	0.00087	CbGpPWpGaD
Topiramate—CA2—Metabolism—GCG—pancreatic cancer	5.17e-05	0.00087	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOE—pancreatic cancer	5.14e-05	0.000865	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOE—pancreatic cancer	5.14e-05	0.000865	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—pancreatic cancer	5.09e-05	0.000857	CbGpPWpGaD
Topiramate—CA4—Metabolism—STK11—pancreatic cancer	5.07e-05	0.000853	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—pancreatic cancer	5.02e-05	0.000845	CbGpPWpGaD
Topiramate—CA1—Metabolism—GCG—pancreatic cancer	4.96e-05	0.000834	CbGpPWpGaD
Topiramate—CA2—Metabolism—STK11—pancreatic cancer	4.86e-05	0.000818	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—pancreatic cancer	4.85e-05	0.000816	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.8e-05	0.000808	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOE—pancreatic cancer	4.8e-05	0.000808	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOE—pancreatic cancer	4.8e-05	0.000808	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP2—pancreatic cancer	4.76e-05	0.000802	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—SRC—pancreatic cancer	4.7e-05	0.00079	CbGpPWpGaD
Topiramate—CA1—Metabolism—STK11—pancreatic cancer	4.66e-05	0.000784	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CG—pancreatic cancer	4.64e-05	0.000781	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CG—pancreatic cancer	4.64e-05	0.000781	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—pancreatic cancer	4.63e-05	0.00078	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—SRC—pancreatic cancer	4.63e-05	0.000779	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—pancreatic cancer	4.57e-05	0.00077	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	4.57e-05	0.000769	CbGpPWpGaD
Topiramate—CA9—Metabolism—CD44—pancreatic cancer	4.54e-05	0.000765	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—pancreatic cancer	4.53e-05	0.000762	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NRAS—pancreatic cancer	4.52e-05	0.00076	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—pancreatic cancer	4.51e-05	0.000758	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PPARG—pancreatic cancer	4.48e-05	0.000754	CbGpPWpGaD
Topiramate—CA6—Metabolism—PPARG—pancreatic cancer	4.48e-05	0.000754	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NRAS—pancreatic cancer	4.45e-05	0.000749	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOE—pancreatic cancer	4.45e-05	0.000749	CbGpPWpGaD
Topiramate—CA4—Metabolism—TYMS—pancreatic cancer	4.36e-05	0.000734	CbGpPWpGaD
Topiramate—CA9—Metabolism—GCG—pancreatic cancer	4.36e-05	0.000733	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CG—pancreatic cancer	4.33e-05	0.000729	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CG—pancreatic cancer	4.33e-05	0.000729	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.2e-05	0.000707	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—pancreatic cancer	4.2e-05	0.000707	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—pancreatic cancer	4.18e-05	0.000704	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—pancreatic cancer	4.18e-05	0.000704	CbGpPWpGaD
Topiramate—CA2—Metabolism—TYMS—pancreatic cancer	4.18e-05	0.000704	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—pancreatic cancer	4.12e-05	0.000693	CbGpPWpGaD
Topiramate—CA9—Metabolism—STK11—pancreatic cancer	4.1e-05	0.000689	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CD—pancreatic cancer	4.08e-05	0.000687	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CD—pancreatic cancer	4.08e-05	0.000687	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—pancreatic cancer	4.05e-05	0.000683	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—pancreatic cancer	4.03e-05	0.000678	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CG—pancreatic cancer	4.01e-05	0.000676	CbGpPWpGaD
Topiramate—CA1—Metabolism—TYMS—pancreatic cancer	4.01e-05	0.000675	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.95e-05	0.000664	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—pancreatic cancer	3.92e-05	0.00066	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—pancreatic cancer	3.89e-05	0.000654	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—pancreatic cancer	3.87e-05	0.000652	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—pancreatic cancer	3.83e-05	0.000645	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CD—pancreatic cancer	3.81e-05	0.000641	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CD—pancreatic cancer	3.81e-05	0.000641	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—pancreatic cancer	3.65e-05	0.000615	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.61e-05	0.000608	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—pancreatic cancer	3.58e-05	0.000603	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CB—pancreatic cancer	3.56e-05	0.000599	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CB—pancreatic cancer	3.56e-05	0.000599	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—pancreatic cancer	3.55e-05	0.000597	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CD—pancreatic cancer	3.53e-05	0.000594	CbGpPWpGaD
Topiramate—CA9—Metabolism—TYMS—pancreatic cancer	3.52e-05	0.000593	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—pancreatic cancer	3.52e-05	0.000593	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—pancreatic cancer	3.52e-05	0.000593	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—pancreatic cancer	3.4e-05	0.000572	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CB—pancreatic cancer	3.32e-05	0.000559	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CB—pancreatic cancer	3.32e-05	0.000559	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—pancreatic cancer	3.3e-05	0.000556	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SRC—pancreatic cancer	3.3e-05	0.000556	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—pancreatic cancer	3.29e-05	0.000554	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—pancreatic cancer	3.29e-05	0.000554	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—pancreatic cancer	3.26e-05	0.000549	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—pancreatic cancer	3.26e-05	0.000548	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—pancreatic cancer	3.22e-05	0.000541	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CG—pancreatic cancer	3.2e-05	0.000539	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—pancreatic cancer	3.18e-05	0.000536	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NRAS—pancreatic cancer	3.18e-05	0.000535	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.16e-05	0.000531	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—pancreatic cancer	3.09e-05	0.00052	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CB—pancreatic cancer	3.08e-05	0.000518	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTEN—pancreatic cancer	3.07e-05	0.000517	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTEN—pancreatic cancer	3.07e-05	0.000517	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—pancreatic cancer	3.07e-05	0.000516	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—pancreatic cancer	3.05e-05	0.000513	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—pancreatic cancer	3.02e-05	0.000509	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—pancreatic cancer	2.96e-05	0.000498	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—pancreatic cancer	2.95e-05	0.000497	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—pancreatic cancer	2.94e-05	0.000495	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—pancreatic cancer	2.92e-05	0.000491	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—pancreatic cancer	2.89e-05	0.000487	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.88e-05	0.000485	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—pancreatic cancer	2.87e-05	0.000483	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTEN—pancreatic cancer	2.87e-05	0.000483	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—pancreatic cancer	2.87e-05	0.000482	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—pancreatic cancer	2.84e-05	0.000478	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CD—pancreatic cancer	2.81e-05	0.000474	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—pancreatic cancer	2.77e-05	0.000466	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—pancreatic cancer	2.76e-05	0.000464	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—pancreatic cancer	2.73e-05	0.00046	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CD—pancreatic cancer	2.7e-05	0.000454	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—pancreatic cancer	2.66e-05	0.000447	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—pancreatic cancer	2.59e-05	0.000435	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CD—pancreatic cancer	2.59e-05	0.000435	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.5e-05	0.00042	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—pancreatic cancer	2.5e-05	0.00042	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CB—pancreatic cancer	2.45e-05	0.000413	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—pancreatic cancer	2.43e-05	0.000409	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—pancreatic cancer	2.42e-05	0.000407	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CB—pancreatic cancer	2.35e-05	0.000396	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—pancreatic cancer	2.33e-05	0.000392	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—pancreatic cancer	2.32e-05	0.000391	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CD—pancreatic cancer	2.27e-05	0.000383	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CB—pancreatic cancer	2.25e-05	0.000379	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—pancreatic cancer	2.23e-05	0.000376	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.18e-05	0.000367	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—pancreatic cancer	2.17e-05	0.000365	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—pancreatic cancer	2.17e-05	0.000365	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—pancreatic cancer	2.12e-05	0.000357	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—pancreatic cancer	2.05e-05	0.000345	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—pancreatic cancer	2.03e-05	0.000342	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—pancreatic cancer	2.02e-05	0.000341	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—pancreatic cancer	2.02e-05	0.000341	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CB—pancreatic cancer	1.98e-05	0.000334	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—pancreatic cancer	1.96e-05	0.000331	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—pancreatic cancer	1.95e-05	0.000328	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—pancreatic cancer	1.87e-05	0.000316	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.8e-05	0.000303	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—pancreatic cancer	1.77e-05	0.000298	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—pancreatic cancer	1.77e-05	0.000298	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.76e-05	0.000296	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.73e-05	0.000292	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.73e-05	0.000291	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—pancreatic cancer	1.71e-05	0.000288	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—pancreatic cancer	1.65e-05	0.000278	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—pancreatic cancer	1.65e-05	0.000278	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.64e-05	0.000277	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.63e-05	0.000274	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.57e-05	0.000264	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—pancreatic cancer	1.53e-05	0.000258	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.5e-05	0.000253	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—pancreatic cancer	1.49e-05	0.000252	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—pancreatic cancer	1.43e-05	0.000241	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.43e-05	0.000241	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—pancreatic cancer	1.37e-05	0.000231	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.31e-05	0.000221	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CD44—pancreatic cancer	1.27e-05	0.000214	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.25e-05	0.00021	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.23e-05	0.000208	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—pancreatic cancer	1.22e-05	0.000206	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCG—pancreatic cancer	1.22e-05	0.000205	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—pancreatic cancer	1.21e-05	0.000203	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—pancreatic cancer	1.17e-05	0.000197	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—STK11—pancreatic cancer	1.15e-05	0.000193	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—pancreatic cancer	1.12e-05	0.000189	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.08e-05	0.000181	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.06e-05	0.000178	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.04e-05	0.000175	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.88e-06	0.000166	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—pancreatic cancer	9.87e-06	0.000166	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TYMS—pancreatic cancer	9.86e-06	0.000166	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—pancreatic cancer	8.02e-06	0.000135	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CD44—pancreatic cancer	7.65e-06	0.000129	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.59e-06	0.000128	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCG—pancreatic cancer	7.33e-06	0.000123	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	7.24e-06	0.000122	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.99e-06	0.000118	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—STK11—pancreatic cancer	6.9e-06	0.000116	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	6.36e-06	0.000107	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.93e-06	9.98e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	5.55e-06	9.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—pancreatic cancer	5.5e-06	9.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—pancreatic cancer	4.82e-06	8.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.79e-06	8.07e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.35e-06	7.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.2e-06	7.07e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.83e-06	6.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.38e-06	5.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.34e-06	5.62e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.31e-06	5.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.88e-06	4.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.76e-06	4.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	3.42e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.66e-06	2.8e-05	CbGpPWpGaD
